In previous studies, BMI-1 protein levels were described to be significantly higher in patients with unfavorable cytogenetics compared with those with intermediate or favorable cytogenetics [25], and CD34 positive AML cells were more susceptible to PTC596 than mature AML cells [26]. This evidence concerns the gene BMI1 and acute myeloid leukemia.